Multiple sclerosis drugs on BlueMedicare Value Rx (S5795-003)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Arkansas
- Premium
- $52.50/month
- Deductible
- $615.00
1 of 8 Multiple sclerosis drugs is covered on this plan. It requires prior authorization.
7 aren't on the formulary, including Kesimpta and teriflunomide.
- $1,249.30Tier 5
Not on the formulary
Kesimpta, teriflunomide, dimethyl fumarate, Vumerity, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.